Last update 01 Nov 2024
Ciclosporin/Prednisolone
Last update 01 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Prednisolone/ciclosporin, Prednisolone/cyclosporine A, Prednisporin + [3] |
Target |
Mechanism CaN inhibitors(Calcineurin inhibitors), GR agonists(Glucocorticoid receptor agonists), PPIB inhibitors(Cyclophilin B inhibitors) + [1] |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC21H28O5 |
InChIKeyOIGNJSKKLXVSLS-VWUMJDOOSA-N |
CAS Registry50-24-8 |
View All Structures (2)
Gene Sequence
Sequence Code 13844772
The sequence is quoted from: *****
Related
1
Clinical Trials associated with Ciclosporin/PrednisoloneA Multi-Center, Randomized, Double-Masked Evaluation of the Efficacy of Co-Administration of FOV1101-00 (Cyclosporine 0.01% or 0.02%) and Prednisolone Acetate 0.12% (PredMild®) Compared to Prednisolone Acetate 1% Alone or Vehicle Alone in Patients With Mild Ongoing Ocular Allergic Inflammation
100 Clinical Results associated with Ciclosporin/Prednisolone
Login to view more data
100 Translational Medicine associated with Ciclosporin/Prednisolone
Login to view more data
100 Patents (Medical) associated with Ciclosporin/Prednisolone
Login to view more data
1
Literatures (Medical) associated with Ciclosporin/Prednisolone13 Jan 2020Journal of Pharmacy and Pharmacology
PXR haplotype clusters will affect the pharmacokinetics of ciclosporin in Chinese renal transplant recipients
Article
Author: Li, Danying ; Ge, Weihong ; Zhu, Huaijun ; Luo, Xuemei
100 Deals associated with Ciclosporin/Prednisolone
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Ocular inflammation | Phase 2 | US | 01 Jan 2009 | |
| Conjunctivitis, Allergic | Phase 2 | - | - | |
| Conjunctivitis, Allergic | Phase 2 | - | - | |
| Conjunctivitis, Allergic | Phase 2 | - | - | |
| Conjunctivitis, Allergic | Phase 2 | - | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Not Applicable | - | - | oahianfapc(uphsfkugzj) = isrwwvuilo qrvipqrxev (rttpzyrjoj ) | - | 01 Apr 2017 | ||
Prednisolone/Everolimus | oahianfapc(uphsfkugzj) = alzvcudpai qrvipqrxev (rttpzyrjoj ) |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free